In line with this, Ly6C+/CX3CR1+/CD88+ moDCs also account for HDC expansion occurring at the onset of experimental NASH, confirming the previous implication of moDC in sustaining liver injury and inflammation in experimental models of chronic steatohepatitis [11]. The gene discussed is C5AR1; the disease is metabolic dysfunction-associated steatohepatitis.